Back to Search
Start Over
Pancreatic enzyme replacement therapy for enterally fed patients with cystic fibrosis.
- Source :
-
Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition [Nutr Clin Pract] 2013 Aug; Vol. 28 (4), pp. 485-9. Date of Electronic Publication: 2013 Jun 10. - Publication Year :
- 2013
-
Abstract
- Administration of pancreatic enzymes (pancrelipase) to adult patients with cystic fibrosis when receiving enteral nutrition through a feeding tube is challenging. A number of techniques for preparing and administering the drug may result in complications that include feeding tube occlusion and inadequate enzyme delivery to the patient. A series of inpatient encounters is described.
- Subjects :
- Adult
Cystic Fibrosis complications
Cystic Fibrosis enzymology
Enteral Nutrition adverse effects
Exocrine Pancreatic Insufficiency etiology
Female
Humans
Male
Pancrelipase administration & dosage
Young Adult
Cystic Fibrosis therapy
Enteral Nutrition methods
Enzyme Replacement Therapy
Exocrine Pancreatic Insufficiency drug therapy
Pancrelipase therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1941-2452
- Volume :
- 28
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition
- Publication Type :
- Academic Journal
- Accession number :
- 23753650
- Full Text :
- https://doi.org/10.1177/0884533613491786